Press Releases - ProAxsis

Press Releases

About

Press Releases

Proaxsis

BTR16 Banner 773x199 1

ProAxsis CEO to present at Biotrinity 2016

Read More

fb pai

“ProActive Investors UK” interviews David Ribeiro

Read More

ats

ProAxsis to present at 2016 American Thoracic Society Conference

Read More

ProAxsis team to attend BIO 2016

Read More

PR8

ProAxsis builds market presence

Read More

ProAxsis featured in Business Eye

Read More

David Ribeiro 300x300 1

ProAxsis CEO to present at Biotech in Europe

Read More

ce markirovka procedura polucheniya sertifikat standart

ProAxsis gains CE Mark for Active Neutrophil Elastase Immunoassay

Read More

conf

ProAxsis to present at 2016 North American Cystic Fibrosis Conference

Read More

PR8

ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016

Read More

btc stop

ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016

Read More

PR8

ProteaseTag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis

Read More

ProAxsis gains backing of Innovate UK

Read More

David Ribeiro 300x300 1

ProAxsis CEO to present update at Bio-Europe Spring

Read More

PR8

ProAxsis abstracts at 2017 American Thoracic Society Conference

Read More

qub

ProAxsis successfully licenses additional intellectual property from The Queen’s University of Belfast

Read More

ELISAkit box 1

ProAxsis technology highlighted in AJRCCM editorial

Read More

David Ribeiro 300x300 1

ProAxsis CEO to present at Anglonordic Conference

Read More

Stanford University Main Quad May 2011 001

ProAxsis’ Active Neutrophil Elastase Immunoassay highlighted in Stanford University trial

Read More

PR8

ProAxsis gains further support from Innovate UK

Read More

NEATstik box 600x600 1 1

ProAxsis registers European CE Mark for first neutrophil elastase point-of-care test

Read More

Paper and stethoscope wide w

ProAxsis abstracts at 2017 European Respiratory Society Conference

Read More

Chemistry w

ProAxsis signs partnership with a large US based biotechnology company

Read More

ProAxsis appoints first distributor for NE Immunoassay

Read More

cff

ProAxsis to showcase ProteaseTag® abstracts at 2017 North American Cystic Fibrosis Conference

Read More

njh

ProAxsis to test ProteaseTag® Technology in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease at National Jewish Health

Read More

NEATstik box 600x600 1

ProAxsis provides update on commercialisation progress

Read More

btc stop

NEATSTIK®ProAxsis abstracts at 2017 British Thoracic Society Winter Meeting

Read More

PR8

ProAxsis Launches ProteaseTag® Active Plasmin Immunoassay following CE Mark registration

Read More

Neatstik presentation 2

ProAxsis reports first NEATstik® sale

Read More

PR8

New opportunity for Early Stage Researcher at Queen’s University Belfast

Read More

ats

ProAxsis Presenting New Data on NEATstik and New High Sensitivity Neutrophil Elastase Immunoassay at ATS 2018

Read More

ProAxsis receives further backing from Invest Northern Ireland under EU investment

Read More

BEFTA presentation

ProAxsis wins Innovative Business of the Year Award

Read More

cropped Web Banner 1

ProAxsis presenting further data at COPD 11 Conference

Read More

PR8

ProAxsis enhances portfolio with new CE Marked Immunoassay

Read More

ERS Paris 300x107 1

ProAxsis presenting new data at 2018 European Respiratory Society Conference

Read More

PR8

ProAxsis assays selected for inclusion in major new ERS-funded study

Read More

BTS

ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting

Read More

NEATstik packaging

New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases

Read More

Undergran awards 2019 1 scaled 1

ProAxsis supports next generation of scientists

Read More

BEFTA shortlisted 300x250 1

ProAxsis shortlisted for Small Business of the Year Award

Read More

PR8

ProAxsis announces new appointments

Read More

PR11

ProAxsis and Ulster University initiate new partnership

Read More

PR9

ProAxsis and the Connected Health Innovation Centre launch new partnership

Read More

PR12

ProAxsis investing in R&D to create new diagnostic tests for chronic human diseases

Read More

PR2

ProAxsis accelerates work on inflammatory biomarkers associated with COVID-19

Read More

PR6

NetScientific acquires 100% control of portfolio company ProAxsis Limited

Read More

PR4

ProAxsis Limited appoints distributor for key North America region

Read More

PR7

ProAxsis Limited recognised as Gold Level Innovator by Innovate NI

Read More

PR2

ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19

Read More

PR5

ProAxsis Limited appoints first distributor for DACH region

Read More

$ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases 53$

ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases

Read More

PR8

ProAxsis Ltd CEO Update Report – End Q4 2021

Read More

AZ Pr 1

ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test

Read More

PR8

Aptamer Group and ProAxsis Limited enter partnership to improve global logistics and stability of diagnostic tests

Read More

PR8

ProAxsis presents exciting new data at the ERS International Congress 2021

Read More

DXPX conference

ProAxsis CEO attending DxPx conference

Read More

DSC 0670 scaled 1

ProAxsis releases new NEATstik® data at the Irish Thoracic Society Conference 2021

Read More

PR8

ProAxsis establishes new internal Finance team

Read More

PR8

ProAxsis expands inflammatory biomarker research via new partnership with Queen’s University Belfast

Read More

PR8

ProAxsis enhances availability of product portfolio in Asia via new partnership with Kyberlife

Read More

virus e1621208944993

ProAxsis signs global in-licensing agreement

Read More

PR8

ProAxsis Ltd CEO Update Report – May 2021

Read More

test tubes in clinic pharmacy and medical research laboratory with male scientist using pipette e1621208937699

Equipping Researchers Lab In The Developing

Read More

research e1621208959587

Patient Experience Better Health Wishes

Read More

btc stop

ProAxsis’ Protease Tag® NE Immunoassay highlighted at BTS 2016

Read More

Protease Tag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis

Read More

PR8

ProAxsis announces additional key appointments

Read More

$Measuring bone health with a new innovation for patients at high risk of osteoporotic fractures 70$

Measuring bone health with a new innovation for patients at high risk of osteoporotic fractures

Read More

PR8

Press release from University of Dundee (re bronchiestasis) May2022

Read More

PR8

Data presentation at ERS

Read More

PR8

ProAxsis and Singapore based Kyberlife announce partnership

Read More

PR8

ProAxsis and Queen’s University of Belfast secure a second licensing agreement for exclusive intellectual property rights ProteaseTag® technology

Read More

PR8

ProAxsis signs partnership agreement with US based Biotechnology company to develop two key respiratory proteases, utilizing ProteaseTag® technology, a platform technology that allows any protease to be targeted

Read More

PR8

Biotech Showcase, BIO Partnering at JPM San Francisco, CA 9-11 January 2023

Read More

PR8

IVD Clinical & Regulatory Affairs Conference San Diego, CA 7-8 February 2023

Read More

PR8

3rd European BronchiectasisMilan, Italy 23-25 February 2023

Read More

PR8

AAAAI (American Academy of Allergy, Asthma and Immunology) Annual Meeting San Antonio, TX 24-27 February 2023

Read More

PR8

Lung Science Conference European Respiratory Society Estoril, Portugal 9-12 March 2023

Read More

PR8

Texas Lung Cancer Conference Austin, TX 30March – 1April 2023

Read More

PR8

Association of Medical Diagnostics Manufacturers IVD Regulatory Meeting Bethesda, MD 19-20 April,2023

Read More

PR8

American Thoracic Society Annual Meeting Washington DC, 19-24 May 2023

Read More

One on One partnering image

ProAxsis attends The Bio International Convention June 5-8, 2023

Read More

ProAxsis announces strengthening of Board and Update on Strategy

Read More